Gajendra Sanjay 4
4 · Astera Labs, Inc. · Filed May 21, 2026
Research Summary
AI-generated summary of this filing
Astera Labs (ALAB) President & COO Gajendra Sanjay Sells Shares
What Happened
Gajendra Sanjay, President, Chief Operating Officer and a director of Astera Labs (ALAB), sold a total of 280,000 shares on May 19, 2026 in multiple open‑market transactions, generating aggregate proceeds of approximately $69,774,015. The sales were executed under a pre‑arranged Rule 10b5‑1 trading plan adopted December 2, 2025.
Key Details
- Transaction date: 2026-05-19; Form 4 filed: 2026-05-21 (no late filing indicated in provided data).
- Sales (each line shows shares / weighted-average price / proceeds):
- 102,839 shares @ $248.91 = $25,597,913 (prices ranged $248.40–$249.395; F2/F7 notes apply)
- 76,702 shares @ $249.79 = $19,159,500 (prices ranged $249.40–$250.39; F4)
- 17,847 shares @ $250.75 = $4,475,066 (prices ranged $250.40–$251.23; F5)
- 2,612 shares @ $251.54 = $657,032 (prices ranged $251.41–$251.80; F6)
- 40,000 shares @ $248.62 = $9,944,704 (prices ranged $248.40–$249.12; F7)
- 40,000 shares @ $248.50 = $9,939,800
- Total: 280,000 shares sold for ~$69.8M.
- Notable footnotes: F1 confirms sales were automatic under a 10b5‑1 plan; F2–F7 explain that reported prices are weighted averages and give per‑tranche price ranges; F3, F8 and F9 note certain shares are held in estate‑planning trusts (Reporting Person disclaims beneficial ownership of those trust‑owned shares).
- Shares owned after the transaction: not disclosed in the excerpt provided.
Context
These were sales, not purchases. Sales executed under a 10b5‑1 plan are typically pre‑arranged and automated, which can indicate routine liquidity rather than a change in the insider’s view of the company; do not infer motivation from the transaction alone. For retail investors, purchases by insiders often carry more direct informational weight than routine sales, though large sales can still be relevant for position sizing or timeline analysis.
Insider Transaction Report
Form 4
Gajendra Sanjay
DirectorPresident and COO
Transactions
- Sale
Common Stock
[F1][F2][F3]2026-05-19$248.91/sh−102,839$25,597,913→ 5,561,374 total(indirect: By Trust) - Sale
Common Stock
[F1][F4][F3]2026-05-19$249.79/sh−76,702$19,159,500→ 5,484,672 total(indirect: By Trust) - Sale
Common Stock
[F1][F5][F3]2026-05-19$250.75/sh−17,847$4,475,066→ 5,466,825 total(indirect: By Trust) - Sale
Common Stock
[F1][F6][F3]2026-05-19$251.54/sh−2,612$657,032→ 5,464,213 total(indirect: By Trust) - Sale
Common Stock
[F1][F7][F8]2026-05-19$248.62/sh−40,000$9,944,704→ 615,000 total(indirect: By Trust) - Sale
Common Stock
[F1][F7][F9]2026-05-19$248.50/sh−40,000$9,939,800→ 615,000 total(indirect: By Trust)
Holdings
- 1,435,857
Common Stock
Footnotes (9)
- [F1]The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $248.4000 to $249.3950, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $249.4000 to $250.3900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $250.4000 to $251.2300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F6]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $251.4100 to $251.8000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F7]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $248.4000 to $249.1200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F8]These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- [F9]These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Signature
/s/ Philip Mazzara, Attorney-in-Fact|2026-05-21